UNION therapys announces positive topline results from investigator-initiated proof-of-concept study OSIRIS of oral orismilast in patients with hidradenitis suppurativa
Oltnews,
Study Demonstrates Clinically Relevant Improvements in Hidradenitis Suppurativa (HS) Patients Receiving 16 Weeks of Orismilast…